My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 144

    1.

    Epoprostenol for pulmonary hypertension in scleroderma.

    Klings ES, Farber HW.

    Ann Intern Med. 2000 Jul 18;133(2):158. No abstract available. PMID: 10896643 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Epoprostenol (prostacyclin) and pulmonary hypertension.

    Fishman AP.

    Ann Intern Med. 2000 Mar 21;132(6):500-2. No abstract available. PMID: 10733452 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Pulmonary hypertension in systemic sclerosis: bete noire no more?

    Varga J.

    Curr Opin Rheumatol. 2002 Nov;14(6):666-70. Review. No abstract available. PMID: 12410089 [PubMed - indexed for MEDLINE]Related articles

    4.

    [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma]

    Humbert M.

    Rev Med Interne. 2007 Dec;28 Suppl 4:S273-6. Epub 2007 Oct 8. French. No abstract available. PMID: 17961866 [PubMed - indexed for MEDLINE]Related articles

    5.

    Acute effects of nebulised epoprostenol in pulmonary hypertension due to systemic sclerosis.

    Parameswaran K, Purcell I, Farrer M, Holland C, Taylor IK, Keaney NP.

    Respir Med. 1999 Feb;93(2):75-8.PMID: 10464856 [PubMed - indexed for MEDLINE]Related articles

    6.

    Targeting mediators of vascular injury in scleroderma.

    Schachna L, Wigley FM.

    Curr Opin Rheumatol. 2002 Nov;14(6):686-93. Review.PMID: 12410092 [PubMed - indexed for MEDLINE]Related articles

    7.

    Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis.

    Distler O, Behrens F, Huscher D, Foeldvari I, Zink A, Nash P, Denton CP, Humbert M, Matucci-Cerinic M, Seibold J, Rubin L, Furst DE.

    Rheumatology (Oxford). 2006 Dec;45(12):1455-7. Epub 2006 Aug 18. No abstract available. PMID: 16920751 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma.

    Farber HW, Graven KK, Kokolski G, Korn JH.

    J Rheumatol. 1999 May;26(5):1195-6.PMID: 10332990 [PubMed - indexed for MEDLINE]Related articles

    9.

    A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism.

    Hachulla E, Coghlan JG.

    Ann Rheum Dis. 2004 Sep;63(9):1009-14. Review.PMID: 15308510 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    [Treatment of scleroderma]

    Mouthon L.

    Rev Prat. 2002 Nov 1;52(17):1915-7. Review. French. PMID: 12532869 [PubMed - indexed for MEDLINE]Related articles

    11.

    Prostacyclin for secondary pulmonary hypertension.

    Kaur K, Brown B, Lombardo F.

    Ann Intern Med. 2000 Jan 18;132(2):165. No abstract available. PMID: 10644284 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A comparison of nesiritide vs. epoprostenol in a patient with precapillary pulmonary hypertension due to scleroderma complicated by postcapillary pulmonary hypertension.

    Zakir RM, Berkowitz RL, Saric M, Ashtyani H.

    Congest Heart Fail. 2005 Nov-Dec;11(6):331-4.PMID: 16330910 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Treatment of pulmonary arterial hypertension associated to systemic sclerosis]

    Hachulla E.

    Rev Med Interne. 2004 Mar;25(3):195-200. Review. French. PMID: 15049280 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of epoprostenol on pulmonary hypertension after pneumonectomy for trauma.

    Brevard S, Weintraub SL, Bronaugh H, Hunt JP, Marr AB.

    J Trauma. 2008 Feb;64(2):496-9. No abstract available. PMID: 18301220 [PubMed - indexed for MEDLINE]Related articles

    15.

    Epoprostenol therapy for primary pulmonary hypertension.

    Cheever KH, Kitzes B, Genthner D.

    Crit Care Nurse. 1999 Aug;19(4):20-7. Review.PMID: 10614244 [PubMed - indexed for MEDLINE]Related articles

    16.

    Endothelin-I receptor antagonist for the treatment of pulmonary arterial hypertension in systemic sclerosis.

    Varga J.

    Curr Rheumatol Rep. 2003 Apr;5(2):145-6. No abstract available. PMID: 12628045 [PubMed - indexed for MEDLINE]Related articles

    17.

    Epoprostenol and nitric oxide therapy for severe pulmonary hypertension in liver transplantation.

    Molmenti EP, Ramsay M, Ramsay K, Lynch K, Tillmann Hein HA, Molmenti H, Levy M, Goldstein R, Ausloos K, East C, Fasola C, Jung G, Escobar J, Klintmalm G.

    Transplant Proc. 2001 Feb-Mar;33(1-2):1332. No abstract available. Erratum in: Transplant Proc 2001 Aug;33(5):2881. PMID: 11267313 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intravenous epoprostenol: a new therapy for primary pulmonary hypertension.

    Sabo JA, Nord CP.

    Crit Care Nurse. 2000 Dec;20(6):31-40. Review. No abstract available. PMID: 11878257 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Pulmonary arterial hypertension and systemic sclerosis]

    Launay D, Humbert M, Hachulla E.

    Presse Med. 2006 Dec;35(12 Pt 2):1929-37. Review. French. PMID: 17159719 [PubMed - indexed for MEDLINE]Related articles

    20.

    Use of epoprostenol (Flolan) in the management of primary pulmonary hypertension.

    Kayser SR.

    Prog Cardiovasc Nurs. 1998 Summer;13(3):39-41, 45. No abstract available. PMID: 9950022 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity